Objectives: Development of an automated MALDI-TOF MS-based method for the rapid, direct detection of carbapenemase-producing Enterobacteriaceae in clinical urine samples within 90 min of sample reception.
Introduction
Urinary tract infection (UTI) is one of the most common types of human bacterial infection. 1, 2 Besides, the spread of carbapenemaseproducing Enterobacteriaceae is an emerging health concern. 3, 4 Urine culture remains the gold standard method, but it is time consuming.
MALDI-TOF MS has recently proved useful for direct identification of bacteria in urine samples. [5] [6] [7] [8] The technique has also been used with good results for detecting b-lactamase activity, [9] [10] [11] [12] [13] [14] [15] [16] [17] although never directly from urine samples. The objective of the present study was to develop a method that can both identify the bacteria and detect carbapenemase-producing Enterobacteriaceae by direct analysis of urine samples.
Materials and methods

Urine sample collection
A total of 3041 samples were collected in the Complejo Hospitalario Universitario A Coruña in May 2016 and were submitted to the Microbiology Laboratory for study ( Figure 1 ). The samples were initially evaluated by automated screening with a urine flow cytometry analyser (UF-1000i; Sysmex, Kobe, Japan). Of these, 608 urine samples with a cut-off of 1.5 % 10 5 bacteria/mL were further selected and processed directly by MALDI-TOF MS for bacterial identification and detection of carbapenemase production.
Routine microbiological processing
The routine protocol included conventional urine culture in Trypticase soy agar (TSA) with 5% sheep blood (Becton Dickinson, NY, USA), MacConkey agar plates (Becton Dickinson) and Colorex V R mSuperCARBA medium (RPD Microbiology). Final identification was performed by MALDI-TOF MS (Bruker Daltonik, GmbH, Bremen, Germany). Urine cultures were considered positive when they yielded 10 4 cfu/mL of one microorganism, whereas samples with two or more different microorganisms were considered contaminated.
Antimicrobial susceptibility testing was performed with the MicroScan Walk-Away V R system (Beckman Coulter, USA). The presence of genes encoding carbapenemases (bla KPC, bla VIM, bla NDM, bla IMP and bla OXA-48 ) in monomicrobial-positive urine cultures containing Gram-negative bacilli was confirmed by PCR and sequencing. 18 Of the 484 Gram-negative bacilli correctly identified by direct MALDI-TOF MS analysis, 30 carried the carbapenemase gene bla OXA-48 . 
Direct identification of bacteria and detection of carbapenemase activity in urine samples by MALDI-TOF MS analysis
Urine samples considered positive because they fulfilled the flow cytometry cut-off were submitted to direct MALDI-TOF MS analysis for bacterial identification and detection of carbapenemase activity. The following protocol was applied. Ten millilitres of urine was centrifuged at 2500 rpm for 30 s to remove cells; the supernatant was then collected and centrifuged at 6000 rpm for 15 min to collect bacteria (i.e. the supernatant was discarded). The pellet was then re-suspended in 500 lL of water, and 40 lL of lysis buffer (Sepsityper Kit; Bruker Daltonik) was added. The sample was vortexed and again centrifuged, at 14 000 rpm for 2 min. Finally, the pellet was washed with 1 mL of the washing buffer (Sepsityper Kit; Bruker Daltonik) and centrifuged at 14 000 rpm for 2 min.
A small part of the pellet was used for bacterial identification, and the rest was used for detection of antibiotic resistance. The pellet was subsequently re-suspended in 50 lL of reaction buffer containing imipenem (Sigma-Aldrich, Germany; 0.25 mg/mL in 10 mM NH 4 HCO 3 /0.005% SDS at pH 8.0). 17 The hydrolysis set-ups were incubated at 37 C for 30 min under agitation. All tests were performed in the presence of positive (Citrobacter freundii, bla VIM-2 ) and negative (Escherichia coli, ATCC 25922) controls.
MALDI-TOF MS analysis and data evaluation
MALDI-TOF MS-based identification was performed in duplicate by direct analysis of the urine sample and 24 h later of the chromogenic medium used to culture the urine for confirmation of the results. A drop of each sample was spread onto a polished steel MALDI target plate and allowed to dry Expected time for identification of bacteria and detection of carbapenemase susceptibility in urine samples by routine microbiological processing. 3 According to the manufacturer, a score of ,1.7 indicates unreliable identification, a score of 1.7 to ,2.0 indicates genus identification and a score 2.0 indicates species identification. 4 Carbapenemase activity was detected directly in urine samples and was measured by MALDI-TOF MS and automated spectra interpretation. LogRQ values ,0.2 represent negative strains, values .0.4 indicate carbapenemase activity and values of 0.2-0.4 represent an ambiguous hydrolysis pattern. 5 Invalid samples were those in which the amount of pellet obtained was not sufficient to carry out direct identification of bacteria and the carbapenem resistance assay. 6 Urine samples were considered positive with 10 4 cfu/mL of one microorganism, whereas samples with two or more microorganisms were considered contaminated. 7 Gram-negative bacilli in positive urine samples were characterized by PCR and further sequencing of carbapenemase genes.
Detection of CPE in urine by MALDI-TOF MS JAC before being covered with 1 lL of 70% formic acid (Sigma-Aldrich) and again allowed to dry. The spots were then covered with the MALDI matrix (10 mg/mL a-cyano-4-hydroxy-cinnamic acid in 50% acetonitrile/0.1% trifluoroacetic acid; Bruker Daltonik). Spectra were acquired in a MALDI Microflex LT/SH bench-top mass spectrometer (Bruker Daltonik) equipped with a 60 Hz nitrogen laser and were analysed with FlexControl v.3.0 software.
In order to detect carbapenemase production by MALDI-TOF MS, duplicate samples (1 lL) of the supernatant obtained after incubation with bacteria extracted from urine and the imipenem solution were spotted directly onto the MALDI target plate. Dried spots were overlaid with 1 lL of MALDI matrix, modified with reserpine. Once the matrix was dry, measurements were made in the mass range between 100 and 1000 Da by employing an optimized acquisition method in the STAR-BL module in FlexControl 3.3 (Bruker Daltonik).
Final identification of the bacteria was conducted with MALDI-TOF Biotyper Compass software (Bruker Daltonik). For evaluating the carbapenemase activity, spectra were analysed in the STAR-BL module of the software. The software automatically calculates the imipenem logRQ value (which indicates the rate of hydrolysis). 17 Positive and negative controls were required to show a difference of at least 0.5 in terms of logRQ in all assays to confirm the results.
Results and discussion
Bacterial identification of urine samples
Analysis of the urine culture results according to the previously established criteria in the routine microbiological processing identified 553 of the 608 samples as positive, 41 as contaminated and 14 as negative (Figure 1 ). In the identification obtained by MALDI-TOF MS from the plate cultures, valid identification was obtained in 100% (553/553) of the cultures following criteria of positive urine infection. Identification to species level was obtained in 92% (509/553) of the samples. The average score of the MALDI-TOF MS ID was 2.269 (minimum 1.824; maximum 2.490) (Table S1 , available as Supplementary data at JAC Online).
Reliable identification of 91% (503/553) of the samples was obtained by direct MALDI-TOF MS analysis of urine samples. Specieslevel identification was obtained in 88% (487/553) of the samples. The average score for the MALDI-TOF MS identification was 2.131 (minimum 1.419; maximum 2.413), i.e. on average 0.138 lower than identification of the plated-derived isolates. Identification of the main pathogen in the urine samples by direct measurement and by measurement after culture was 100% consistent. The main pathogen present was E. coli (377/503, 75%), followed by Klebsiella pneumoniae (86/503, 17%).
S anchez-Juanes et al. 7 improved the direct identification of bacteria in urine by pretreatment of the samples with SDS to enhance cell lysis. Application of a protein extraction procedure to the bacterial pellet has been reported to improve direct identification by MALDI-TOF MS; 5 however, as the bacteria are also needed for direct detection of carbapenemase resistance, a protein extraction protocol with formic acid and acetonitrile was not suitable for use in the present study. The Sepsityper Kit (Bruker Daltonik) shows excellent results regarding the capacity for extraction of bacteria with intact enzyme activity, which is essential in hydrolysis assays conducted by MALDI-TOF MS. One microlitre of 70% formic acid is added to the sample directly in the MALDI-TOF target, to increase spectral quality when bacteria are identified, as use of this reagent does not interfere in the resistance assay.
Valid identification was not obtained by direct analysis of urine in 9% of the samples in the study. This may be explained by the presence of contaminating bacteria in the samples and/or the unsuccessful removal of urine cells during the extraction procedure.
Direct carbapenem susceptibility testing in urine samples by MALDI-TOF Detection of carbapenemase resistance was performed directly in 484 out of the 503 urine samples in which Gram-negative bacteria were identified. Nine samples carrying Gram-positive bacteria and 10 samples in which the pellet obtained occupied ,15 lL of the volume and was not large enough to perform both direct identification and the carbapenemase resistance assay were excluded Oviaño et al.
from the analysis (Figure 1 ). The results obtained by direct testing of urine samples with imipenem as antibiotic marker and automated interpretation spectra revealed 100% sensitivity (30/30) and specificity (454/454) for detection of carbapenemase resistance (Table 1 and Table S1 ). Among the positive urine samples for carbapenemase activity, 28 of the pathogens were identified as K. pneumoniae and 2 as E. coli; all were further characterized as OXA-48-type producers. The mean logRQ value for imipenem hydrolysis was 0.86. The STAR-BL software (Bruker Daltonik) has proved a great improvement over qualitative methods, enabling automatic spectra interpretation. Use of this software is especially important for imipenem, as the hydrolysis reaction is only followed by the disappearance of the mass peak at 300 m/z, and no stable hydrolysed product is recognized. Besides, the software reduces the intra-and inter-observer-related variability in the assay, thus providing standardized results. Another advantage of the method is that bacterial identification and detection of antimicrobial resistance can be performed in the same run and target plate with the MALDI-TOF Biotyper Compass software (Bruker Daltonik).
The method has some limitations, such as the high input volume (10 mL) of urine required, the need for bacterial counts higher than or equal to 1.5 % 10 5 bacteria/mL and the exclusive testing of carbapenemase activity if correct identification is previously achieved. Another limitation of the study is the exclusive identification of monomicrobial infections. Reliable identification is not usually obtained when more than one pathogen is present (data not shown). Although this is not usual in urine infections, in which monomicrobial infections are the most common and important, the software must be developed further to improve identification of mixed bacteriuria.
Conclusions
MALDI-TOF MS is a valuable method for identifying bacteria and detecting carbapenemase activity in urine samples, providing results within 90 min after sample reception, thus reducing the time required to process urine samples by 24-48 h in cases of monomicrobial infection and facilitating the implementation of appropriate empirical treatment.
